MRUS
Merus N.V. Healthcare - Biotechnology Investor Relations →
Merus N.V. (MRUS) closed at $90.00 as of 2025-12-29, trading 127.8% above its 200-week moving average of $39.51. The stock is currently moving closer to the line, down from 147.3% last week. With a 14-week RSI of 80, MRUS is in overbought territory.
Over the past 454 weeks of data, MRUS has crossed below its 200-week moving average 16 times. On average, these episodes lasted 10 weeks. Historically, investors who bought MRUS at the start of these episodes saw an average one-year return of +46.8%.
With a market cap of $6.8 billion, MRUS is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -51.6%. The stock trades at 8.8x book value.
Share count has increased 58.3% over three years, indicating dilution.
Over the past 8.8 years, a hypothetical investment of $100 in MRUS would have grown to $405, compared to $328 for the S&P 500. That represents an annualized return of 17.3% vs 14.6% for the index — confirming MRUS as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
In the past 12 months, corporate insiders have made 3 open-market purchases totaling $132,446,904. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: MRUS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After MRUS Crosses Below the Line?
Across 16 historical episodes, buying MRUS when it crossed below its 200-week moving average produced an average return of +48.1% after 12 months (median +44.0%), compared to +19.8% for the S&P 500 over the same periods. 81% of those episodes were profitable after one year. After 24 months, the average return was +85.6% vs +39.9% for the index.
Each line shows $100 invested at the moment MRUS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
MRUS has crossed below its 200-week MA 16 times with an average 1-year return of +46.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 2017 | Jul 2017 | 4 | 15.1% | +22.3% | +479.3% |
| Jul 2017 | Sep 2017 | 9 | 18.4% | +42.9% | +452.1% |
| Oct 2017 | Dec 2017 | 9 | 12.5% | -14.9% | +458.0% |
| Feb 2018 | Feb 2018 | 1 | 4.3% | -25.3% | +460.0% |
| Oct 2018 | Sep 2019 | 48 | 34.7% | +4.5% | +472.9% |
| Sep 2019 | Dec 2019 | 10 | 10.7% | -26.8% | +447.4% |
| Dec 2019 | Jan 2020 | 3 | 18.6% | +18.2% | +485.6% |
| Jan 2020 | Feb 2020 | 1 | 1.5% | +68.3% | +450.5% |
| Mar 2020 | Nov 2020 | 38 | 37.0% | +40.8% | +453.2% |
| Dec 2020 | Dec 2020 | 1 | 2.9% | +89.3% | +462.5% |
| May 2022 | May 2022 | 3 | 13.4% | +16.1% | +402.2% |
| Sep 2022 | Sep 2022 | 1 | 1.0% | +28.2% | +381.8% |
| Oct 2022 | Mar 2023 | 19 | 31.1% | +45.8% | +427.2% |
| Mar 2023 | Apr 2023 | 2 | 5.7% | +144.7% | +389.1% |
| Apr 2023 | May 2023 | 1 | 1.9% | +134.8% | +369.2% |
| Oct 2023 | Oct 2023 | 2 | 1.9% | +159.6% | +343.3% |
| Average | 10 | — | +46.8% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2025-12-29